Mira Pharmaceuticals, Inc. - Sep 29, 2025 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
10%+ Owner
Signature
/s/ Erez Aminov, CEO
Stock symbol
TELO
Transactions as of
Sep 29, 2025
Transactions value $
$0
Form type
3
Date filed
10/3/2025, 08:00 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MIRA PHARMACEUTICALS, INC. 10%+ Owner 1200 BRICKELL AVE. SUITE 1950 #1183, MIAMI /s/ Erez Aminov, CEO 2025-10-03 0001904286

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TELO Common Stock, no par value 3.52M Sep 29, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 3,521,127 shares of the Issuer's common stock, no par value, acquired in connection with the Reporting Person's acquisition of SKNY Pharmaceuticals, Inc.